Company profile
Cero Therapeutics Holdings, Inc. Insider Trading
CEROEvery SEC Form 4 insider trading filing for Cero Therapeutics Holdings, Inc. (CERO) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- OTC
- Sector
- Biological Products, (No Diagnostic Substances)
- CIK
- 0001870404
- Filings
- 66
- Insiders
- 22
- Last filing
- 2026-03-04
Activity summary
No insider transactions in the last 30 days. The most recent was on March 4, 2026, when Eric Francois bought 1,823,278 shares. 66 filings from 22 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q1 24 to Q1 26. Cero Therapeutics Holdings, Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $5.3M.
No insider activity recorded for CERO in the last 90 days.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 4, 2026 | Eric Francois | CERO | Award | 1,823,278 | — | — |
| Jan 7, 2026 | Brian G Atwood | CERO | Award | 1,612,099 | — | — |
| Jan 7, 2026 | Michael Byrnes | CERO | Award | 690,900 | — | — |
| Jan 7, 2026 | Kristen Pierce | CERO | Award | 1,612,099 | — | — |
| Jan 7, 2026 | Shami Patel | CERO | Award | 690,900 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=CERO" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.